ArticleVaccines2022

Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study.

Suvimol Niyomnaitham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.